查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球胃肠道治疗药物市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测
市场调查报告书
商品编码
1305288

全球胃肠道治疗药物市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

Global Gastrointestinal Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 350 Pages | 商品交期: 最快1-2个工作天内

价格

据预测，到2030年，全球胃肠道治疗药物市场需求将从2022年的488.6亿美元增至803.8亿美元，2023-2030年的复合年增长率为6.42%。

胃肠道治疗药物可治疗胃肠道疾病，即影响结肠、小肠、大肠和直肠的消化系统问题。这种胃肠道慢性炎症性疾病主要影响结肠粘膜。便秘、消化性溃疡病和肠易激综合征是最常见的疾病，症状包括不适、腹胀、腹泻、恶心和呕吐。胃肠道治疗药物包括Aciphex、Afinitor、akynzeo、deficit和Prilosec等市售药物。

市场动态：

胃肠道疾病发病率的上升也提高了对胃肠道治疗药物的需求，以改善医疗服务，改变生活方式，提高工业化和卫生水平，这将促进市场增长。许多研发机构正在研究新的治疗方法，预计这将推动胃肠道治疗市场的扩张。由于越来越多的临床研究结果可靠，以及医疗保健支出的增加，胃肠道治疗药物的市场正在扩大。老龄化人口不断增加，这将加速市场扩张，因为他们更容易出现此类健康问题。然而，胃肠道治疗药物的市场扩张可能会受到相关疗法和药物的副作用以及政府对药物审批的严格限制的阻碍。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球胃肠道治疗药物市场的各个细分市场进行了全面评估。胃肠道治疗药物行业的增长和趋势为本研究提供了整体方法。

市场细分：

胃肠道治疗药物市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按类型

  • 品牌药
  • 仿制药

按药物类别

  • 氨基水杨酸盐
  • 消化酶
  • 质子泵抑制剂
  • 泻药
  • 抗化妆品
  • H2拮抗剂
  • 止泻药
  • 生物制剂/生物类似药
  • 其他

按给药途径

  • 口服
  • 注射剂
  • 其他

按应用分类

  • 克罗恩病
  • 溃疡性结肠炎
  • 胃肠病
  • 肠易激综合征
  • 其他

按销售渠道

  • 医院药房
  • 零售药店
  • 网上药店

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美以及中东和非洲地区胃肠道治疗药物市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。胃肠道治疗药物市场的主要参与者包括艾伯维公司、阿斯利康公司、杨森制药公司、太阳制药工业有限公司、武田药品株式会社、Salix制药公司、辉瑞公司、拜耳公司、雅培公司、Cipla公司、吉利德科学公司、百健公司、Organon集团公司。本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

如果您有任何定制要求，请联系我们。我们的研究团队可以根据您的需求提供定制报告。

目 录

第一章：前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章：执行摘要

  • 市场亮点
  • 全球市场概况

第三章：胃肠道治疗药物-行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按药物类别的市场吸引力分析
    • 按给药途径的市场吸引力分析
    • 市场吸引力分析：按应用
    • 市场吸引力分析：按销售渠道
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章：Covid-19爆发的影响分析

第六章：全球胃肠道治疗药物市场分析：按类型划分

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 品牌药
  • 仿制药

第七章 ：全球胃肠道治疗药物市场分析：按药物类别划分

  • 按药物类别概述
  • 历史和预测数据
  • 按药物类别分析
  • 氨基水杨酸盐
  • 消化酶
  • 质子泵抑制剂
  • 泻药
  • 抗化妆品
  • H2拮抗剂
  • 止泻药
  • 生物制剂/生物类似药
  • 其他

第八章：全球胃肠道治疗药物市场分析：按给药途径分类

  • 给药途径概述
  • 历史和预测数据
  • 按给药途径分析
  • 口服
  • 注射剂
  • 其他

第九章：全球胃肠道治疗药物市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 克罗恩病
  • 溃疡性结肠炎
  • 胃食管反流病
  • 肠易激综合征
  • 其他

第10章：全球胃肠道治疗药物市场分析：按销售渠道划分

  • 分销渠道概述
  • 历史和预测数据
  • 按销售渠道分析
  • 医院药房
  • 零售药店
  • 网上药店

第十一章 ：全球胃肠道治疗药物市场分析：按地域划分

  • 顶级公司份额分析
  • 公司简介
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美地区销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区各细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲各细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东及非洲其他地区销售分析

第十二章 ：胃肠道治疗药物公司的竞争格局

  • 胃肠道治疗药物市场竞争格局
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品上市
  • 其他发展

第十三章 ：公司概况

  • 公司份额分析
  • 市场集中度
  • AbbVie Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • AstraZeneca
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Janssen Pharmaceuticals NV
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Sun Pharmaceutical Industries Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Takeda Pharmaceutical Company Limited
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Salix Pharmaceuticals
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Bayer AG
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Abbott
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Cipla Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Gilead Sciences Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Biogen
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Organon Group of Companies
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

Product Code: VMR112110049

The global demand for Gastrointestinal Therapeutics Market is presumed to reach the market size of nearly USD 80.38 BN by 2030 from USD 48.86 BN in 2022 with a CAGR of 6.42% under the study period 2023 - 2030.

Gastrointestinal therapeutics treats gastrointestinal disorders, which are digestive system issues affecting the colon, small and large intestines, and rectum. This chronic inflammatory illness of the gastrointestinal tract mainly affects the colon's mucosal lining. Constipation, peptic ulcer diseases, and irritable bowel syndrome are the most common conditions, with symptoms such as discomfort, bloating, diarrhoea, nausea, and vomiting. Gastrointestinal therapeutics include commercially accessible medication such as Aciphex, Afinitor, akynzeo, deficit, and Prilosec.

Market Dynamics:

The rising prevalence of gastrointestinal disorders is also raising demand for gastrointestinal therapeutics to enhance better healthcare access, to change lifestyles, and for higher rates of industrialization and sanitation, which will increase the market growth. Numerous R&D organizations are investigating new therapeutic modalities, which are anticipated to boost the market expansion of gastrointestinal therapeutics. The market for gastrointestinal therapeutics is expanding due to more clinical studies with reliable outcomes and rising healthcare expenditure. The ageing population is growing, which will accelerate market expansion because they are more prone to such health problems. However, the market expansion of gastrointestinal therapeutics can be hampered by related side effects of therapies and medication and strict governmental restrictions for drug approval.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gastrointestinal therapeutics. The growth and trends of gastrointestinal therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the gastrointestinal therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Branded
  • Generics

By Drug Class

  • Aminosalicylates
  • Digestive Enzymes
  • Proton Pump Inhibitors
  • Laxatives
  • Anti-Emetics
  • H2 Antagonists
  • Anti-Diarrheal
  • Biologics/Biosimilar
  • Others

By Route Of Administration

  • Oral
  • Injectable
  • Others

By Application

  • Crohn'S Disease
  • Ulcerative Colitis
  • Gerd
  • IBS
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Gastrointestinal Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gastrointestinal therapeutics market include AbbVie Inc., AstraZeneca, Janssen Pharmaceuticals NV, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Salix Pharmaceuticals, Pfizer Inc., Bayer AG, Abbott, Cipla Inc., Gilead Sciences Inc., Biogen, Organon Group of Companies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GASTROINTESTINAL THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Drug Class
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Branded Historic and Forecast Sales by Regions
  • 6.5 Generics Historic and Forecast Sales by Regions

7 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

  • 7.1 Overview by Drug Class
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Drug Class
  • 7.4 Aminosalicylates Historic and Forecast Sales by Regions
  • 7.5 Digestive Enzymes Historic and Forecast Sales by Regions
  • 7.6 Proton Pump Inhibitors Historic and Forecast Sales by Regions
  • 7.7 Laxatives Historic and Forecast Sales by Regions
  • 7.8 Anti-Emetics Historic and Forecast Sales by Regions
  • 7.9 H2 Antagonists Historic and Forecast Sales by Regions
  • 7.10. Anti-Diarrheal Historic and Forecast Sales by Regions
  • 7.11 Biologics/Biosimilar Historic and Forecast Sales by Regions
  • 7.12 Others Historic and Forecast Sales by Regions

8 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 8.1 Overview by Route Of Administration
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Route Of Administration
  • 8.4 Oral Historic and Forecast Sales by Regions
  • 8.5 Injectable Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Crohn's Disease Historic and Forecast Sales by Regions
  • 9.5 Ulcerative Colitis Historic and Forecast Sales by Regions
  • 9.6 GERD Historic and Forecast Sales by Regions
  • 9.7 IBS Historic and Forecast Sales by Regions
  • 9.8 Others Historic and Forecast Sales by Regions

10 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 10.1 Overview by Distribution Channel
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Distribution Channel
  • 10.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 10.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 10.6 Online Pharmacies Historic and Forecast Sales by Regions

11 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE GASTROINTESTINAL THERAPEUTICS COMPANIES

  • 12.1. Gastrointestinal Therapeutics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF GASTROINTESTINAL THERAPEUTICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. AbbVie Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. AstraZeneca
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Janssen Pharmaceuticals NV
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Sun Pharmaceutical Industries Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Takeda Pharmaceutical Company Limited
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Salix Pharmaceuticals
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Pfizer Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Bayer AG
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Abbott
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Cipla Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Gilead Sciences Inc.
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Biogen
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. Organon Group of Companies
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Branded Market Sales by Geography (USD MN)
  • Generics Market Sales by Geography (USD MN)
  • Analysis Market by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Digestive Enzymes Market Sales by Geography (USD MN)
  • Proton Pump Inhibitors Market Sales by Geography (USD MN)
  • Laxatives Market Sales by Geography (USD MN)
  • Anti-Emetics Market Sales by Geography (USD MN)
  • H2 Antagonists Market Sales by Geography (USD MN)
  • Anti-Diarrheal Market Sales by Geography (USD MN)
  • Biologics/Biosimilar Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • GERD Market Sales by Geography (USD MN)
  • IBS Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Gastrointestinal Therapeutics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gastrointestinal Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Gastrointestinal Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Branded Market Sales by Geography (USD MN)
  • Generics Market Sales by Geography (USD MN)
  • Global Market Analysis by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Digestive Enzymes Market Sales by Geography (USD MN)
  • Proton Pump Inhibitors Market Sales by Geography (USD MN)
  • Laxatives Market Sales by Geography (USD MN)
  • Anti-Emetics Market Sales by Geography (USD MN)
  • H2 Antagonists Market Sales by Geography (USD MN)
  • Anti-Diarrheal Market Sales by Geography (USD MN)
  • Biologics/Biosimilar Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • GERD Market Sales by Geography (USD MN)
  • IBS Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.